LNWTC
RMD icon

Laird Norton Wetherby Trust Company’s ResMed RMD Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.33M Sell
5,937
-29
-0.5% -$7.23K 0.03% 411
2025
Q4 		$1.44M Buy
+5,966
New +$1.53M 0.03% 400

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Laird Norton Wetherby Trust Company's RMD Position: Q1 2026 in Review

Laird Norton Wetherby Trust Company reduced its ResMed (RMD) stake by 0.49% in Q1 2026, selling an estimated $7.23K and leaving 5,937 shares worth $1.33M. The position accounts for 0.03% of the portfolio, ranked #411.

Laird Norton Wetherby Trust Company first reported a position in RMD in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.44M in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Laird Norton Wetherby Trust Company held 5,937 shares of ResMed worth $1.33M as of Q1 2026.
  • Laird Norton Wetherby Trust Company sold 29 ResMed shares in Q1 2026, an estimated $7.23K.
  • ResMed made up 0.03% of Laird Norton Wetherby Trust Company's portfolio in Q1 2026, its #411 holding.
  • Laird Norton Wetherby Trust Company first reported a position in ResMed in Q4 2025 and has held it in 2 quarters since.
  • Laird Norton Wetherby Trust Company's ResMed position peaked at $1.44M in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q1 2026, filed 15 May 2026.